Brain-Derived Neurotrophic Factor Role in Autism Remains Elusive: A Flashback on the Route That Has Brought Us Here
Abstract
No Abstract
Mintz M. Evolution in the Understanding of Autism Spectrum Disorder: Historical Perspective. Indian J Pediatr 2017;84:44-52
Cross-Disorder Group of the Psychiatric Genomics Consortium. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 2013;381:1371-9.
Wang M, Chen H, Yu T, Cui G, Jiao A, Liang H. Increased serum levels of brain-derived neurotrophic factor in autism spectrum disorder. Neurorepor. 2015;26:638-41.
Meng WD, Sun SJ, Yang J, Chu RX, Tu W, Liu Q. Elevated Serum Brain-Derived Neurotrophic Factor (BDNF) but not BDNF Gene Val66Met Polymorphism Is Associated with Autism Spectrum Disorders. Mol Neurobiol 2016;54:1167-72.
Saghazadeh A, Rezaei N. Brain-derived neurotrophic factor levels in autism: a systematic review and meta-analysis. J Autism Dev Disord. 2017;47(4):1018-1029.
Elsworth JD, Groman SM, Jentsch JD, Leranth C, Redmond DE, Jr., Kim JD, et al. Primate phencyclidine model of schizophrenia: sex-specific effects on cognition, brain derived neurotrophic factor, spine synapses, and dopamine turnover in prefrontal cortex. Int J Neuropsychopharmacol 2014;18:pii: pyu048.
Chen L, Pan H, Tuan TA, Teh AL, MacIsaac JL, Mah SM, et al. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism influences the association of the methylome with maternal anxiety and neonatal brain volumes. Dev Psychopathol 2015;27:137-50.
Isgor C, Pare C, McDole B, Coombs P, Guthrie K. Expansion of the dentate mossy fiber-CA3 projection in the brain-derived neurotrophic factor-enriched mouse hippocampus. Neuroscience 2015;288:10-23.
Gkampeta A, Fidani L, Clarimon J, Kalinderi K, Katopodi T, Zafeiriou D, et al. Association of brain-derived neurotrophic factor (BDNF) and elongator protein complex 4 (ELP4) polymorphisms with benign epilepsy with centrotemporal spikes in a Greek population. Epilepsy Res 2014;108:1734-9.
Matsuo J, Kamio Y, Takahashi H, Ota M, Teraishi T, Hori H, et al. Autistic-like traits in adult patients with mood disorders and schizophrenia. PLoS One 2015;10:e0122711.
Wang Z, Li Z, Gao K, Fang Y. Association between brain-derived neurotrophic factor genetic polymorphism Val66Met and susceptibility to bipolar disorder: a meta-analysis. BMC Psychiatry 2014;14:366.
Bonaccorso S, Sodhi M, Li J, Bobo WV, Chen Y, Tumuklu M, et al. The brain-derived neurotrophic factor (BDNF) Val66Met polymorphism is associated with increased body mass index and insulin resistance measures in bipolar disorder and schizophrenia. Bipolar Disord 2015;17:528-35.
Naert G, Zussy C, Tran Van Ba C, Chevallier N, Tang YP, Maurice T, et al. Involvement of Endogenous Brain-Derived Neurotrophic Factor in Hypothalamic-Pituitary-Adrenal Axis Activity. J Neuroendocrinol 2015;27:850-60.
Craig F, Lamanna AL, Margari F, Matera E, Simone M, Margari L. Overlap Between Autism Spectrum Disorders and Attention Deficit Hyperactivity Disorder: Searching for Distinctive/Common Clinical Features. Autism Res 2015;8:328-37
Rivero O, Selten MM, Sich S, Popp S, Bacmeister L, Amendola E, et al. Cadherin-13, a risk gene for ADHD and comorbid disorders, impacts GABAergic function in hippocampus and cognition. Transl Psychiatry 2015;5:e655.
| Files | ||
| Issue | Vol 55, No 12 (2017) | |
| Section | Editorial | |
| Keywords | ||
| No keywords## | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
